Abemaciclib,Anastrozole,Letrozole
Eli Lilly,Novartis
['monarch 3', 'abema', 'increase,(-increased)', 'abemaciclib', 'medsir']
promising results from the second interim analysis of monarch 3 trial presented by dr. . though without statistical significance, abemaciclib + nsai in postmenopausal pts with hr+, her2- abc highly increase os (by &gt;12 mo) in both the itt population and svd. #esmo2022 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM